Article Details
Retrieved on: 2025-07-23 22:28:32
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ublituximab, developed by TG Therapeutics and licensed by Neuraxpharm ex-US, is a novel anti-CD20 monoclonal antibody approved in the United States, ...
Article found on: pharmaceuticalmanufacturer.media
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here